11min chapter

Newscast cover image

Weighing Up Diet Drugs

Newscast

CHAPTER

Semaglutide: From Diabetes Treatment to Weight Loss Wonder Drug

The chapter explores the drug Semaglutide, highlighting its potential 20% reduction in heart attack or stroke risk. It delves into its journey from a diabetes treatment to a popular weight loss drug, discussing the regulatory challenges in prescribing such medications in the UK NHS. The chapter also addresses concerns around prescribing drugs outside of licenses and the skepticism surrounding a study funded by Novo Nordisk, emphasizing the importance of further research for validation.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode